✦ LIBER ✦

The added value of concurrently administered temozolomide versus adjuvant temozolomide alone in newly diagnosed glioblastoma

✍ Scribed by David J. Sher; John W. Henson; Bindu Avutu; Fred H. Hochberg; Tracy T. Batchelor; Robert L. Martuza; Fred G. Barker; Jay S. Loeffler; Arnab Chakravarti

Publisher: Springer US
Year: 2008
Tongue: English
Weight: 180 KB
Volume: 88
Category: Article
ISSN: 0167-594X
DOI: 10.1007/s11060-008-9530-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A retrospective study of the safety of B

A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients

✍ Edward Pan; Susan B. Mitchell; Jerry S. Tsai 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 188 KB

Commentary on effects of radiotherapy wi

Commentary on effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-Year analysis of the EORTC-NCIC trial (Lancet Oncol. 2009;10:459-466)

✍ Ute Linz 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB